"This story is about the development of my heroin addiction and my recovery from it. I struggled to escape from addiction for 17 years, but only succeeded after an ibogaine treatment. It is autobiographical, but I only describe traumatic episodes that contributed to addiction and sketch the highlights and milestones in my recovery. It is a memoir, as it offers a thematic view of my life and is moderate in scope; and a personal essay in which I offer insights about society’s role in addiction. My intent is that addicts and their loved ones may better understand the nature of addiction so their approaches to treatment are better informed and more compassionate.
At 66, I am a gentleman/hipster/Seeker and scholar, but I’m not an armchair academic who wrote this book from a library: I was an addict for 22 years! Now I am blessed to be alive and have 18 years clean. My mission is to help addicts by educating the public and the professional community about addiction’s complexity and the efficacy of ibogaine for its treatment. I hope my story supports a change in social and medical attitudes so that the unheard voices of addicts will be honored, instead of just seeing them as social problems.
Addiction put my life into suspended animation when I had a third of the credits I needed for a bachelor’s degree. 27 years later I returned to school; now I have bachelor’s degrees in Anthropology and Psychology and a Master’s degree in East-West Psychology (EWP). I am currently a PhD. candidate in EWP at the California Institute of Integral Studies in San Francisco, California." - Adrian Auler
MAPS Multidisciplinary Association for Psychedelic Studies offers the following information about ibogaine.
Ibogaine is a psychoactive alkaloid naturally occurring in the West African shrub iboga. While ibogaine is a mild stimulant in small doses, in larger doses it induces a profound psychedelic state. Historically, it has been used in healing ceremonies and initiations by members of the Bwiti religion in various parts of West Africa. People with problem substance use have found that larger doses of ibogaine can significantly reduce withdrawal from opiates and temporarily eliminate substance-related cravings.
Although first-hand accounts indicate that ibogaine is unlikely to be popular as a recreational drug, ibogaine remains classified as a Schedule I drug in the United States (it is also scheduled in Belgium and Switzerland). Yet despite its classification as a drug with a “high potential for abuse” and “no currently accepted medical use,” people who struggle with substance abuse continue to seek out international clinics or underground providers to receive ibogaine treatment.